In some high-risk, aggressive or metastatic tumors, such as the pancreatic, uterine cervix, papillary thyroid, and ovarian cancers, SLPI was often found to be highly expressed [40, 41]. This evidence concerns the gene SLPI and ovarian carcinoma.